ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

KURA Kura Oncology Inc

17.53
-0.15 (-0.85%)
20 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Kura Oncology Inc KURA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.15 -0.85% 17.53 07:46:02
Open Price Low Price High Price Close Price Previous Close
17.61 16.79 17.90 17.53 17.68
more quote information »

Recent News

Date Time Source Heading
10/4/202421:30GLOBEKura Oncology to Participate in Stifel Targeted Oncology..
05/4/202422:30GLOBEKura Oncology Reports Inducement Grants Under Nasdaq Listing..
06/3/202423:30GLOBEKura Oncology Reports First Patient Dosed in Trial of..
02/3/202409:00GLOBEKura Oncology Reports Inducement Grants Under Nasdaq Listing..
28/2/202408:52EDGAR2Form S-8 - Securities to be offered to employees in employee..
28/2/202408:03EDGAR2Form 8-K - Current report
28/2/202408:01GLOBEKura Oncology Reports Fourth Quarter and Full Year 2023..
26/2/202423:30GLOBEKura Oncology Doses First Patient in KOMET-008 Trial of..
22/2/202423:30GLOBEKura Oncology to Participate in Three Upcoming Investor..
20/2/202423:30GLOBEKura Oncology to Report Fourth Quarter and Full Year 2023..
16/2/202408:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/2/202416:15EDGAR2Form EFFECT - Notice of Effectiveness
15/2/202409:58EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202409:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
10/2/202409:21EDGAR2Form S-3 - Registration statement under Securities Act of..
02/2/202423:30GLOBEKura Oncology Reports Inducement Grants Under Nasdaq Listing..
01/2/202409:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202409:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202409:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202408:10EDGAR2Form 144 - Report of proposed sale of securities
30/1/202423:08EDGAR2Form 8-K - Current report
30/1/202423:00GLOBEKura Oncology Reports Positive Preliminary Ziftomenib..
27/1/202409:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/1/202408:08EDGAR2Form 8-K - Current report
25/1/202408:12EDGAR2Form 144 - Report of proposed sale of securities
24/1/202423:00GLOBEKura Oncology Announces Oversubscribed $150 Million Private..
05/1/202408:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202408:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202408:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202408:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202408:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202408:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202301:01EDGAR2Form 8-K - Current report
12/12/202308:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202323:30GLOBEKura Oncology’s Menin Inhibitor Ziftomenib Selected for The..
28/11/202323:30GLOBEKura Oncology to Participate in the JMP Securities..
03/11/202307:39EDGAR2Form S-3ASR - Automatic shelf registration statement of..
03/11/202307:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202307:03EDGAR2Form 8-K - Current report
03/11/202307:01GLOBEKura Oncology Reports Third Quarter 2023 Financial Results
02/11/202322:30GLOBEKura Oncology and Mirati Therapeutics Enter into Clinical..
30/10/202322:30GLOBEKura Oncology to Participate in Three Upcoming Investor..
27/10/202307:05GLOBEKura Oncology to Report Third Quarter 2023 Financial Results
19/10/202322:30GLOBEKura Oncology Announces First Patient Dosed in FIT-001 Trial..
18/10/202307:05GLOBEKura Oncology Announces Positive Results from..
04/10/202322:30GLOBEKura Oncology Announces Three Presentations at..
28/9/202321:30GLOBEKura Oncology Reports Preclinical Data Showing Ability of..
19/9/202321:30GLOBEKura Oncology to Participate in Cantor Global Healthcare..
02/9/202306:05EDGAR2Form 8-K - Current report
17/8/202306:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

Delayed Upgrade Clock